𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study

✍ Scribed by Philip D. Harvey; Michael F. Green; Susan R. McGurk; Herbert Y. Meltzer


Publisher
Springer
Year
2003
Tongue
English
Weight
167 KB
Volume
169
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Treatment of adductor spasticity with BT
✍ Volker Mall; Andrea Siebel; Christoph Bertram; Ulrich Hafkemeyer; JΓΆrg Wissel; S πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 105 KB

Adductor spasticity in children with cerebral palsy **(CP)** impairs motor function and development. In a placebo‐controlled, double‐blind, randomized multicentre study, we evaluated the effects of botulinum toxin **A(BTX‐A)** in 61 children (37 males, 24 females; mean age 6 years 1 month [SD 3y 1mo

Lymphoid irradiation in intractable rheu
✍ John G. Hanly; Jaythoon Hassan; Michael Moriarty; Ciaran Barry; Jack Molony; Eoi πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 907 KB

Twenty patients with intractable rheumatoid arthritis were treated with 750-rad or 2,000-rad lymphoid irradiation in a randomized double-blind comparative study. Over a 12-month followup period, there was a significant improvement in 4 of 7 and 6 of 7 standard parameters of disease activity followin

Randomized double-blind placebo-controll
✍ Gregory H. Pelton; Oliver L. Harper; Matthias H. Tabert; Harold A. Sackeim; Niko πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 97 KB πŸ‘ 2 views

## Abstract ## Objective To assess combined antidepressant and cognitive enhancer treatment in elderly patients presenting with depression plus cognitive impairment. ## Methods Twenty‐three elderly (>50 years old) depressed, cognitively impaired (DEP‐CI) patients participated in a pilot study. W

Efficacy of selegiline add on therapy to
✍ Afshar Amiri; Ahmad-Ali Noorbala; Ali-Akbar Nejatisafa; Abolfazl Ghoreishi; Moha πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 100 KB

## Abstract ## Objective It has been reported that selegiline, a Selective Monoamine Oxidase Inhibitor B (MAOI‐B), at low doses would be helpful for treating negative symptoms in schizophrenia. Nevertheless, the results are contradictory so far. This study was designed to investigate the effect of